Suppr超能文献

抗生素对未分化状态、多能性、细胞活力和生长的人类胚胎干细胞中支原体的作用。

Effect of antibiotics against Mycoplasma sp. on human embryonic stem cells undifferentiated status, pluripotency, cell viability and growth.

机构信息

Laboratorio de Biología del Desarrollo Celular, Laboratorios de Investigación Aplicada en Nuerociencias - Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia, Escobar, Buenos Aires, Argentina .

出版信息

PLoS One. 2013 Jul 30;8(7):e70267. doi: 10.1371/journal.pone.0070267. Print 2013.

Abstract

Human embryonic stem cells (hESCs) are self-renewing pluripotent cells that can differentiate into specialized cells and hold great promise as models for human development and disease studies, cell-replacement therapies, drug discovery and in vitro cytotoxicity tests. The culture and differentiation of these cells are both complex and expensive, so it is essential to extreme aseptic conditions. hESCs are susceptible to Mycoplasma sp. infection, which is hard to detect and alters stem cell-associated properties. The purpose of this work was to evaluate the efficacy and cytotoxic effect of Plasmocin(TM) and ciprofloxacin (specific antibiotics used for Mycoplasma sp. eradication) on hESCs. Mycoplasma sp. infected HUES-5 884 (H5 884, stable hESCs H5-brachyury promoter-GFP line) cells were effectively cured with a 14 days Plasmocin(TM) 25 µg/ml treatment (curative treatment) while maintaining stemness characteristic features. Furthermore, cured H5 884 cells exhibit the same karyotype as the parental H5 line and expressed GFP, through up-regulation of brachyury promoter, at day 4 of differentiation onset. Moreover, H5 cells treated with ciprofloxacin 10 µg/ml for 14 days (mimic of curative treatment) and H5 and WA09 (H9) hESCs treated with Plasmocin(TM) 5 µg/ml (prophylactic treatment) for 5 passages retained hESCs features, as judged by the expression of stemness-related genes (TRA1-60, TRA1-81, SSEA-4, Oct-4, Nanog) at mRNA and protein levels. In addition, the presence of specific markers of the three germ layers (brachyury, Nkx2.5 and cTnT: mesoderm; AFP: endoderm; nestin and Pax-6: ectoderm) was verified in in vitro differentiated antibiotic-treated hESCs. In conclusion, we found that Plasmocin(TM) and ciprofloxacin do not affect hESCs stemness and pluripotency nor cell viability. However, curative treatments slightly diminished cell growth rate. This cytotoxic effect was reversible as cells regained normal growth rate upon antibiotic withdrawal.

摘要

人胚胎干细胞(hESCs)是自我更新的多能细胞,可分化为特化细胞,在人类发育和疾病研究、细胞替代疗法、药物发现和体外细胞毒性测试中具有巨大的应用前景。这些细胞的培养和分化既复杂又昂贵,因此必须在极端无菌条件下进行。hESCs 容易感染支原体,支原体感染难以检测,并且会改变与干细胞相关的特性。本研究旨在评估 Plasmocin(TM)和环丙沙星(用于消除支原体的特定抗生素)对 hESCs 的疗效和细胞毒性作用。通过 Plasmocin(TM) 25 µg/ml 治疗(治愈性治疗),可以有效治疗感染支原体的 HUES-5 884(H5 884,稳定的 hESCs H5-brachyury 启动子-GFP 系)细胞,同时保持干细胞特征。此外,治愈的 H5 884 细胞在分化开始的第 4 天通过 brachyury 启动子的上调表达 GFP,其核型与亲本 H5 系相同。此外,用环丙沙星 10 µg/ml 处理 14 天(模拟治愈性治疗)的 H5 细胞和用 Plasmocin(TM) 5 µg/ml 处理 5 代的 H5 和 WA09(H9)hESCs 保留了 hESCs 的特征,这可通过 mRNA 和蛋白水平上的干细胞相关基因(TRA1-60、TRA1-81、SSEA-4、Oct-4、Nanog)的表达来判断。此外,在体外分化的抗生素处理的 hESCs 中验证了三个胚层的特定标志物(brachyury、Nkx2.5 和 cTnT:中胚层;AFP:内胚层;nestin 和 Pax-6:外胚层)的存在。总之,我们发现 Plasmocin(TM) 和环丙沙星既不影响 hESCs 的干性和多能性,也不影响细胞活力。然而,治愈性治疗略微降低了细胞生长速度。这种细胞毒性作用是可逆的,因为细胞在抗生素去除后恢复了正常的生长速度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73fb/3728093/ec7b32583ac0/pone.0070267.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验